Michael Feld, the EVP & President of $BDX, sold 57 shares of the company on 08-22-2025 for an estimated $11,285. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their shares of this class of stock. Following this trade, they now own 8,360 shares of this class of $BDX stock.
$BDX Insider Trading Activity
$BDX insiders have traded $BDX stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- GREGORY HAYES purchased 5,250 shares for an estimated $1,005,742
- RICHARD BYRD (EVP & President Interventional) has made 0 purchases and 2 sales selling 2,399 shares for an estimated $541,895.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 3 sales selling 1,664 shares for an estimated $308,141.
- DAVID SHAN (EVP and Chief ISC Officer) sold 1,166 shares for an estimated $199,607
- CLAIRE FRASER sold 863 shares for an estimated $165,954
- MICHAEL FELD (EVP & President, Life Sciences) sold 57 shares for an estimated $11,285
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BDX Hedge Fund Activity
We have seen 701 institutional investors add shares of $BDX stock to their portfolio, and 924 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 4,598,284 shares (-53.5%) from their portfolio in Q2 2025, for an estimated $792,054,419
- VANGUARD GROUP INC added 4,305,947 shares (+15.4%) to their portfolio in Q2 2025, for an estimated $741,699,370
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,603,168 shares (+28.7%) to their portfolio in Q2 2025, for an estimated $620,645,688
- BLACKROCK, INC. added 3,389,963 shares (+14.2%) to their portfolio in Q2 2025, for an estimated $583,921,126
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 3,268,478 shares (+59.2%) to their portfolio in Q2 2025, for an estimated $562,995,335
- GQG PARTNERS LLC removed 3,011,583 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $518,745,171
- GENERATION INVESTMENT MANAGEMENT LLP removed 2,537,140 shares (-47.9%) from their portfolio in Q2 2025, for an estimated $437,022,365
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/15 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 05/13.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BDX Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/03/2025
- Morgan Stanley issued a "Overweight" rating on 05/06/2025
- Stifel issued a "Buy" rating on 05/02/2025
To track analyst ratings and price targets for $BDX, check out Quiver Quantitative's $BDX forecast page.
$BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 7 analysts offer price targets for $BDX in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Patrick Wood from Morgan Stanley set a target price of $197.0 on 08/11/2025
- Jason Bednar from Piper Sandler set a target price of $200.0 on 08/08/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $184.0 on 08/08/2025
- Matt Miksic from Barclays set a target price of $241.0 on 06/03/2025
- Joanna Wiensch from Citigroup set a target price of $185.0 on 05/22/2025
- Rick Wise from Stifel set a target price of $224.0 on 05/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
